The Flowr Corporation Stock Toronto S.E.
Equities
FLWR.H
CA34354X1087
Pharmaceuticals
Sales 2020 | 7.51 10.24 | Sales 2021 | 12.35 16.83 | Capitalization | 22.37M 30.49M |
---|---|---|---|---|---|
Net income 2020 | -126M -172M | Net income 2021 | -85M -116M | EV / Sales 2020 | 16,546,858 x |
Net Debt 2020 | 29.2M 39.8M | Net Debt 2021 | 17.1M 23.31M | EV / Sales 2021 | 3,196,178 x |
P/E ratio 2020 |
-0.35
x | P/E ratio 2021 |
-0.24
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 65.85% |
1st Jan change | Capi. | |
---|---|---|
+12.92% | 4.95B | |
-32.29% | 3.6B | |
-4.28% | 3.03B | |
-24.21% | 2.66B | |
-8.82% | 2.34B | |
+39.33% | 1.85B | |
+40.81% | 1.45B | |
-14.27% | 1.41B | |
+41.90% | 1.38B |